Genitourinary Cancer section

Genitourinary Cancer News & Features

Age, Race, Sex Affect Survival for Patients With HPV-Associated Cancers

Age, Race, Sex Affect Survival for Patients With HPV-Associated Cancers

Using a data sample from the CDC National Program for Cancer Registries, investigators determined how demographic factors — age, race, and sex — impact 5-year survival rates for HPV-associated cancers from initial diagnosis until death.

New Tool Identifies Mortality Risk After Bladder Cancer Surgery

New Tool Identifies Mortality Risk After Bladder Cancer Surgery

Tool incorporates the relative contribution of tumor stage and lymph node involvement.

First-line Pembrolizumab May Be Efficacious for Cisplatin-ineligible Urothelial Cancer

First-line Pembrolizumab May Be Efficacious for Cisplatin-ineligible Urothelial Cancer

Approximately 50% of patients with advanced urothelial carcinoma are unable to receive standard first-line cisplatin-based chemotherapy, indicating a need for additional treatment options.

Risk of Bladder Recurrence Reduced With Chemotherapy Flush After Tumor Resection

Risk of Bladder Recurrence Reduced With Chemotherapy Flush After Tumor Resection

Flushing the bladder with a chemotherapeutic agent after tumor resection significantly reduced recurrence rates of bladder cancer.

Cabozantinib Active in Hepatocellular Carcinoma

Cabozantinib Active in Hepatocellular Carcinoma

Treatment with cabozantinib was active and associated with manageable toxicities in patients with hepatocellular carcinoma.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs